Nuvectis Pharma Announces Participation at Upcoming Investor Conferences

Fort Lee, NJ, Sept. 01, 2023 -- Nuvectis Pharma, Inc. , a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious...

Related Keywords

New York ,United States ,Christopherm Calabrese ,Ron Bentsur ,Drug Administration ,Nuvectis Pharma Inc ,Company Contact ,Nasdaq ,Fort Lee ,Chief Executive Officer ,Annual Global Investment Conference ,Global Healthcare Conference ,Nuvectis Pharma ,Fast Track Designation ,Orphan Drug Designation ,New Drug Application ,Markets ,